Dr. William Morgan, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,025 | 59 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $282.52 | 15 | $0 (2024) |
| Lilly USA, LLC | $202.03 | 11 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $87.82 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $82.68 | 6 | $0 (2024) |
| Amgen Inc. | $77.49 | 5 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $76.18 | 4 | $0 (2024) |
| Exact Sciences Corporation | $54.10 | 3 | $0 (2024) |
| ABBVIE INC. | $32.98 | 2 | $0 (2024) |
| Boston Scientific Corporation | $28.36 | 2 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.61 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $529.85 | 30 | Novo Nordisk Inc ($165.53) |
| 2023 | $305.11 | 17 | Lilly USA, LLC ($111.29) |
| 2022 | $136.84 | 8 | Lilly USA, LLC ($51.36) |
| 2021 | $11.19 | 1 | Novo Nordisk Inc ($11.19) |
| 2020 | $11.34 | 1 | PFIZER INC. ($11.34) |
| 2019 | $11.14 | 1 | AstraZeneca Pharmaceuticals LP ($11.14) |
| 2017 | $19.56 | 1 | Otsuka America Pharmaceutical, Inc. ($19.56) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Respiratory | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/18/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Inflammation | ||||||
| 06/03/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Obesity | ||||||
| 05/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/10/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Obesity | ||||||
| 04/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/08/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 3,978 | 7,840 | $460,994 | $225,900 |
| 2022 | 34 | 3,312 | 6,151 | $366,902 | $173,484 |
| 2021 | 39 | 2,363 | 4,036 | $234,629 | $121,264 |
| 2020 | 23 | 1,077 | 1,399 | $90,511 | $47,566 |
All Medicare Procedures & Services
138 procedure records from CMS Medicare Utilization — Page 2 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 19 | $1,102 | $743.22 | 67.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 20 | 149 | $2,831 | $625.80 | 22.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 11 | $2,151 | $542.91 | 25.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 106 | 194 | $2,328 | $421.73 | 18.1% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 22 | 26 | $1,326 | $409.55 | 30.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 47 | 59 | $885.00 | $319.39 | 36.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $322.00 | $315.56 | 98.0% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 16 | 17 | $884.00 | $270.13 | 30.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 24 | 25 | $1,525 | $263.00 | 17.2% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 16 | 16 | $928.00 | $254.38 | 27.4% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 15 | 16 | $504.00 | $174.91 | 34.7% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 27 | 27 | $675.00 | $164.97 | 24.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 26 | 26 | $520.00 | $132.08 | 25.4% |
| 84550 | Uric acid level, blood | Office | 2023 | 21 | 27 | $1,107 | $116.80 | 10.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 54 | $540.00 | $57.80 | 10.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 20 | 80 | $800.00 | $30.68 | 3.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 69 | 356 | $712.00 | $30.21 | 4.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 343 | 900 | $126,000 | $71,784 | 57.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 273 | 725 | $69,600 | $48,080 | 69.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 44 | 50 | $10,000 | $7,633 | 76.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 102 | 135 | $18,495 | $4,084 | 22.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 304 | 511 | $15,330 | $3,901 | 25.4% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 243 | 427 | $20,069 | $3,570 | 17.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 244 | 312 | $18,408 | $3,229 | 17.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 62 | 73 | $6,132 | $3,140 | 51.2% |
About Dr. William Morgan, MD
Dr. William Morgan, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Houston, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2017. The National Provider Identifier (NPI) number assigned to this provider is 1316477607.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Morgan, MD has received a total of $1,025 in payments from pharmaceutical and medical device companies, with $529.85 received in 2024. These payments were reported across 59 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,025).
As a Medicare-enrolled provider, Morgan has provided services to 10,730 Medicare beneficiaries, totaling 19,426 services with total Medicare billing of $568,214. Data is available for 4 years (2020–2023), covering 138 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Houston, MS
- Active Since 06/19/2017
- Last Updated 07/02/2020
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1316477607
Products in Payments
- Ozempic (Drug) $190.11
- MOUNJARO (Drug) $183.26
- VOQUEZNA (Drug) $87.82
- Rybelsus (Drug) $81.23
- GVOKE HYPOPEN (Drug) $76.18
- Cologuard Collection Kit (Device) $54.10
- BREZTRI (Drug) $52.75
- Otezla (Drug) $47.49
- VRAYLAR (Drug) $32.98
- Repatha (Biological) $30.00
- General - Pain Management (Device) $28.36
- OFEV (Drug) $19.61
- SAMSCA (Drug) $19.56
- AIRSUPRA (Drug) $18.79
- ZEPBOUND (Drug) $18.77
- TRELEGY ELLIPTA (Drug) $18.72
- Xhance (Drug) $16.67
- YUPELRI (Drug) $14.97
- ELIQUIS (Drug) $11.34
- Wegovy (Drug) $11.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Houston
Sandeep Sahay, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $366,850
Diego Marines Copado, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $287,975
Dr. Eddie Patton, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $235,342
Naveen Pemmaraju, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $198,556
Laila Tabatabai, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $194,524
Syed Naqvi, M.d./M.b.a, M.D./M.B.A
Student in an Organized Health Care Education/Training Program — Payments: $144,401